Related Experiment Video
Updated: Aug 6, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
O-GlcNAcylation Regulation of SNAP29-Dependent Autophagy Activation Dictates Chemoresistance in Gastric Cancer
Liang Tang1, Shaoji Zhao1, Ziling Shao1
1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
Abstract:
Chemoresistance remains a major obstacle in gastric cancer (GC) treatment, particularly to standard fluoropyrimidine and platinum regimens. O-GlcNAc transferase (OGT) and O-linked β-N-acetylglucosamine modification (O-GlcNAcylation) are frequently elevated in cancers, yet their specific role in GC chemotherapy remains poorly defined. Contrary to its typical oncogenic function, this study demonstrates that low OGT/O-GlcNAcylation is associated with resistance to 5-fluorouracil (5-FU) or oxaliplatin (OXA) in GC. Clinically, high OGT expression correlates with better prognosis in patients receiving fluoropyrimidine/platinum chemotherapy. Functionally, OGT knockdown or O-GlcNAcylation inhibition promotes chemoresistance both in vitro and in vivo. Mechanistically, OGT interacts with and O-GlcNAcylates synaptosomal-associated protein 29 (SNAP29) at Ser2, Ser61, Thr130, and Ser153. This modification inhibits STX17-SNAP29-VAMP8 complex assembly and autophagosome maturation. Molecular dynamics simulations suggest this involves disruption of inter-chain hydrogen bonds and increased flexibility at SNAP29 termini. Loss of SNAP29 O-GlcNAcylation relieves this suppression, enhances protective autophagy, and drives chemoresistance. Additionally, acute 5-FU or OXA treatment downregulates OGT and O-GlcNAcylation, potentially initiating a feedforward resistance loop. Importantly, elevating O-GlcNAcylation with Thiamet-G sensitizes GC tumors to chemotherapy in vivo. These findings reveal a context-dependent role for the OGT/SNAP29 axis in regulating chemoresistance via autophagy and nominate OGT as a promising therapeutic target in GC.
Insights
Low O-GlcNAc transferase (OGT) and O-linked β-N-acetylglucosamine modification (O-GlcNAcylation) levels paradoxically promote chemoresistance in gastric cancer (GC). Enhancing O-GlcNAcylation sensitizes GC to chemotherapy, identifying OGT as a therapeutic target.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Chemoresistance to fluoropyrimidine and platinum agents is a major challenge in gastric cancer (GC).
- The role of O-GlcNAc transferase (OGT) and O-GlcNAcylation in GC chemoresistance is not well understood.
- OGT is often elevated in cancers, but its function in GC chemotherapy response is unclear.
Purpose of the Study:
- To investigate the role of OGT and O-GlcNAcylation in GC chemoresistance.
- To elucidate the molecular mechanisms underlying OGT's function in GC chemotherapy response.
- To evaluate OGT as a potential therapeutic target for overcoming GC chemoresistance.
Main Methods:
- Analysis of OGT expression and patient prognosis in GC.
- In vitro and in vivo experiments involving OGT knockdown and O-GlcNAcylation inhibition.
- Mechanistic studies using protein interaction assays, mass spectrometry, and molecular dynamics simulations.
- Assessment of autophagy pathway modulation and response to chemotherapy agents (5-FU, OXA).
- Evaluation of Thiamet-G as an O-GlcNAcylation enhancer in vivo.
Main Results:
- Low OGT/O-GlcNAcylation levels correlate with resistance to 5-FU or oxaliplatin (OXA) in GC.
- High OGT expression is associated with better prognosis in GC patients receiving fluoropyrimidine/platinum chemotherapy.
- OGT inhibition or knockdown enhances chemoresistance, while OGT upregulation or O-GlcNAcylation enhancement sensitizes tumors to chemotherapy.
- OGT O-GlcNAcylates SNAP29, inhibiting STX17-SNAP29-VAMP8 complex formation and autophagosome maturation.
- Loss of SNAP29 O-GlcNAcylation promotes autophagy and chemoresistance.
- Chemotherapy treatment downregulates OGT and O-GlcNAcylation, potentially creating a resistance loop.
- Thiamet-G treatment sensitizes GC tumors to chemotherapy in vivo.
Conclusions:
- The OGT/SNAP29 axis plays a context-dependent role in regulating GC chemoresistance through autophagy.
- Low OGT/O-GlcNAcylation promotes chemoresistance by enhancing protective autophagy.
- Targeting OGT or enhancing O-GlcNAcylation represents a promising strategy to overcome chemoresistance in gastric cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Regulation of Nuclear Protein Sorting

